Study Overview

This study will look at a new dry powder to be mixed with water before oral administration. The study medication is called rivaroxaban and it can be taken orally, as a liquid with the dose adjusted to the weight of your child.

Study Eligibility

Children from 6 months to 12 years of age will be enrolled in the study. You have been asked to have your child take part in this research study because he/she has been diagnosed and completed treatment for a blood clot.


For more information about this study, contact D’Ann Pierce, RN at 501-364-4440.